Clinical trial
The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit
NCT00282594 · Genesys, Other · Completed
Key facts
| NCT number | NCT00282594 |
|---|---|
| Title | The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit |
| Official title | No Outcome Benefit for the Use of Intensive Insulin Therapy in the Critically Ill General and Vascular Surgical Patient. A Randomized Prospective Trial. |
| Lead sponsor | Genesys, Other |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sepsis, Respiratory Failure, Renal Failure, Surgical Site Infection |
| Intervention type | Drug |
| Interventions | Novolin R (human recombinant Insulin) |
| Enrollment | 317 |
| Start date | Jul 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Jan 27, 2006 |
| Last update posted | Jan 27, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: